MedPath

Impact of Peritoneal Gas Drain on Postoperative Pain for Gynaecological Cancer Patients With Minimally Invasive Surgery

Not Applicable
Completed
Conditions
Gynaecologic Cancer
Interventions
Procedure: Drain
Procedure: Manual exsufflation
Registration Number
NCT04974125
Lead Sponsor
Centre Oscar Lambret
Brief Summary

This is a phase III, monocenter and randomized study, which evaluates the effectiveness of peritoneal gas drainage on postoperative pain in laparoscopic or robotic laparoscopic gynaecological surgery. This study aim is to assess the efficacy of active gas extraction with a drain (arm A) in comparison to manual evacuation (arm B,) in terms of pain incidence reduction linked to laparoscopic or robotic laparoscopic surgery.

Detailed Description

The primary objective is to assess the efficacy of active gas aspiration compared to simple manual gas evacuation to reduce the incidence of specific laparoscopic surgery pain.

Secondary objectives of this study include :

* Comparing the evolution of specific pains after laparoscopic surgery, between study groups

* Description of postoperative antalgics consumption in each group

* Evaluating the safety of the evaluated procedure

* Evaluating the impact of the evaluated procedure on hospitalisation duration ( for patients with ambulatory surgery initially planned)

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
202
Inclusion Criteria
  • Age ≥ 18 ans ;
  • Woman who underwent laparoscopic or robotised laparoscopic surgery in peritoneal cavity (benign or malignant gynaecological affection) ;
  • Planned ambulatory surgery
  • Patient willing and able to be treated and followed according the protocol during the trial ;
  • Patient covered by the French "Social Security" regime ;
  • Effective contraception for reproductive age patients ;
  • Signed written informed consent before surgery

Per-operatory eligibility criterion :

  • No conversion from laparoscopic surgery to laparotomy surgery
Exclusion Criteria
  • Extra-peritoneal surgery scheduled ( example : aortic dissection) ;
  • Upper-abdomen surgery (example : liver, gall bladder) ;
  • History of shoulders pains prior to surgery (the assessment must be carried out within a period of 30 days before the surgery) ;
  • Inability to comply with medical follow-up of the trial (geographical, social or psychic reasons)
  • Person under guardianship
  • Pregnant or breastfeeding woman

Non eligibility criterion known during the operation :

  • Conversion from laparoscopic surgery to laparotomy surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm A :Aspiration of peritoneal gas through a drainDrainPatients in experimental arm will receive surgery (either laparoscopic or robotised laparoscopic surgery). The exsufflation will be carrying out by a drain. Then, patients will be followed-up during 7 days after surgery.
Arm B : Manual evacuation of the peritoneal gas, via the trocarManual exsufflationLaparoscopic or robotised laparoscopic surgery + Trocar Patient in this experimental arm will receive surgery (either laparoscopic or robotised laparoscopic surgery). The exsufflation will be carrying out carried out manually using the trocar (standard of care).Then, patient will be followed-up during 7 days after surgery.
Primary Outcome Measures
NameTimeMethod
Specific pain (shoulders and/or subcostal areas) related to the laparoscopic surgery (Day 0), measured with a numerical pain assessment scale (score from 0 to 10)During the 24 hours after surgery

Comparison on portion of patients with significative early pain linked to the laparoscopic surgery, between the two groups (Chi-2 tests).

Secondary Outcome Measures
NameTimeMethod
Maximal score pain, measured with a numerical pain assessment scale (score from 0 to 10)24 hours after surgery

The maximum score pain will be evaluated by the mean difference between each group (Student or Mann-Whitney tests).

Adverse events (AE) (grade ≥III Clavien-Dindo classification)30 days after surgery

Safety procedure will be describe through adverse events notification potentially related to the procedure and their grade (total amount of AE, maximal grade of AE per patient).

Evaluate the impact of the evaluated procedure on the hospitalisation durationThrough the study patient participation, an average of 2 months

Impact of the peritoneal gas aspiration technique on the hospitalisation duration for patient with ambulatory surgery.

Assess pain at trocar holes comparatively in the two groups24 hours after surgery

The site of pain will be reported to describe pain overall, but also specifically in the shoulders and/or subcostal areas and pain at trocar holes.

Pain will be measured with the numerical pain assessment scale (score from 0 to 10).

Laparoscopic surgery specific pains, measured with a numerical pain assessment scale (score from 0 to 10)7 days after surgery

A notebook filled in by the patient at home with a daily assessment of pain according to the numerical pain assessment scale, with a phone call from the nurse on day 7 (considering that the day of the surgery is day 0).

Antalgics consumption24 hours and 7 days after surgery

Quantitative description through patient notebook.

Trial Locations

Locations (1)

Fabrice NARDUCCI

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath